Visa Faces Shareholder Challenge Over Transgender Healthcare Coverage Policies

A major shareholder proposal at Visa's upcoming annual meeting challenges the company's healthcare policies regarding gender transition procedures, highlighting growing concerns about corporate liability and healthcare coverage gaps for detransitioners.

February 4, 2025
Visa Faces Shareholder Challenge Over Transgender Healthcare Coverage Policies

Visa, Inc. will face scrutiny over its transgender healthcare coverage policies at its annual meeting Tuesday, as shareholder National Legal and Policy Center (NLPC) presents a proposal examining potential risks and disparities in the company's health benefits system. The proposal specifically questions Visa's coverage policies for gender transition procedures while allegedly lacking equivalent support for detransition care.

Claire Abernathy, a 20-year-old detransitioner, will address Visa's board to share her personal experience with transition procedures that began at age 12, highlighting concerns about rushed medical interventions and subsequent difficulties accessing care to address complications. The testimony brings attention to a growing debate about corporate liability and healthcare coverage gaps for individuals who reverse gender transitions.

The shareholder proposal points to potential legal and financial risks for Visa, citing the Equal Employment Opportunity Commission's stance on benefit discrimination based on gender identity. The proposal follows similar initiatives at other major corporations, including Disney, Johnson & Johnson, and PepsiCo, reflecting broader concerns about corporate policies regarding gender-related healthcare coverage.

This development signals increasing scrutiny of corporate healthcare policies amid rising detransitioner lawsuits against medical providers. For investors and corporations, the issue presents both ethical and financial considerations, as companies could face legal challenges over their healthcare coverage decisions. The outcome of this shareholder proposal could influence how other major corporations approach transgender healthcare coverage and detransition care in their benefits packages.